<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Farooq</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Ahmad</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sarwar</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Shafiq</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Raza</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>Rifampicin conjugated silver nanoparticles: a new arena for development of antibio fi lm potential against methicillin resistant Staphylococcus aureus and 
   <italic>Klebsiella pneumoniae</italic>.
  </article-title>
  <source>
   <italic>Int. J. Nanomedicine</italic>
  </source>
  <volume>14</volume>
  <fpage>3983</fpage>â€“
  <lpage>3993</lpage>. 
  <pub-id pub-id-type="doi">10.2147/ijn.s198194</pub-id>
  <?supplied-pmid 31213810?>
  <pub-id pub-id-type="pmid">31213810</pub-id>
 </mixed-citation>
</ref>
